Effect of fluoroqmnolones on the in-vitro proliferation of myeloid precursor cells
- 1 August 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 24 (2) , 203-208
- https://doi.org/10.1093/jac/24.2.203
Abstract
The effects of three fluoroquinoloncs (ofloxacin, pefloxacin and rufloxacin) on the in-vitro proliferation of murine myeloid cells were studied. Their activity was compared with that of nalidixic acid and novobiocin. Therapeutic concentrations of quinolones do not affect the physiological course of myelopoiesis. Only very high concentrations of drug ( > 70 mg/l) affect bone marrow cell growth producing a dose-dependent inhibition. Because quinolones are active on topoisomerase II from eukaryotic cells they can modulate mammalian cell growth.Keywords
This publication has 2 references indexed in Scilit:
- 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitroAntimicrobial Agents and Chemotherapy, 1987
- Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.Proceedings of the National Academy of Sciences, 1984